What is the clinical evidence from this study?

Study design: Editorial. Population: Valvular heart disease. Intervention: 2025 ESC/EACTS Guideline vs. 2020 ACC/AHA Guideline.

February 28, 2026Open Access

Reconciling the 2025 ESC/EACTS Valvular Heart Disease Guideline With ACC/AHA Guidance: Convergence, Divergence, and Implications for Practice

Resultado clave

The 2025 ESC/EACTS guideline introduces substantive revisions in the management of valvular heart disease, diverging from ACC/AHA guidance regarding age-based TAVI recommendations, atrial secondary MR, and earlier tricuspid intervention.

PICO

Población

Valvular heart disease

Intervención / comparador

2025 ESC/EACTS Guideline vs 2020 ACC/AHA Guideline

Me gusta

Guardar

Ver artículo completo

Me gusta

Guardar

Ver artículo completo

Cite This Study

Abouemera et al. (Mon,) conducted a editorial in Valvular heart disease. 2025 ESC/EACTS Guideline vs. 2020 ACC/AHA Guideline was evaluated. The 2025 ESC/EACTS guideline introduces substantive revisions in the management of valvular heart disease, diverging from ACC/AHA guidance regarding age-based TAVI recommendations, atrial secondary MR, and earlier tricuspid intervention.

synapsesocial.com/papers/6a025a8a9cddff7633412d31 https://doi.org/https://doi.org/10.31083/bjhm50387